← back to search

Jeffrey M. Farma

Merck Institute for Science Education · US
🔎 Find collaborators in Oncology · Pulmonary and Respiratory Medicine →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Cutaneous Melanoma Detection and Management, Colorectal Cancer Surgical Treatments, Sarcoma Diagnosis and Treatment, and Nonmelanoma Skin Cancer Studies.
h-index
37
citations
6,342
works
231
NIH funding
primary concept
Medicine
email

Recent publications

Dermatofibrosarcoma Protuberans, Version 1.2025, NCCN Clinical Practice Guidelines In Oncology
Journal of the National Comprehensive Cancer Network 2025cited by 26position: middledoi
Current Management of Desmoid Tumors
JAMA Oncology 2024cited by 73position: middledoi
NCCN Guidelines® Insights: Merkel Cell Carcinoma, Version 1.2024
Journal of the National Comprehensive Cancer Network 2024cited by 48position: middledoi
The Use of Gene Expression Profiling and Biomarkers in Melanoma Diagnosis and Predicting Recurrence: Implications for Surveillance and Treatment.
2024cited by 19position: contributordoi
A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first‐line treatment for patients with melanoma in‐transit metastases
Cancer 2024cited by 8position: middledoi
Combined programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 blockade in an international cohort of patients with acral lentiginous melanoma
British Journal of Dermatology 2024cited by 7position: middledoi
Novel MIR143HG::PLAG1 gene fusion identified in a rectal myxoid leiomyosarcoma.
2024cited by 1position: contributordoi
Preoperative Treatment of Locally Advanced Rectal Cancer
New England Journal of Medicine 2023cited by 427position: middledoi
Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048)
Journal of Clinical Oncology 2023cited by 132position: middledoi
Basal Cell Skin Cancer, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network 2023cited by 112position: middledoi
Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048).
2023cited by 103position: contributordoi
Special clinical scenarios in RPS: Involvement of great vessels and pancreas and penetration across natural foramina
European Journal of Surgical Oncology 2023cited by 2position: contributordoi
Management of Locally Recurrent Retroperitoneal Sarcoma in the Adult: An Updated Consensus Approach from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group
Annals of Surgical Oncology 2022cited by 45position: middledoi
Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma
JAMA Surgery 2022cited by 43position: middledoi
Suppression of Ca<sup>2+</sup> signaling enhances melanoma progression.
2022cited by 19position: contributordoi
Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection
Journal for ImmunoTherapy of Cancer 2022cited by 15position: middledoi
Retrospective Analysis of Retroperitoneal-Abdominal-Pelvic Ganglioneuromas
Annals of Surgery 2022cited by 12position: middledoi
A Virtual Tumor Board Platform: A Way to Enhance Decision-Making for Complex Malignancies
Journal of Surgical Research 2022cited by 6position: contributordoi
NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022
Journal of the National Comprehensive Cancer Network 2021cited by 141position: middledoi
Active surveillance of patients who have sentinel node positive melanoma: An international, multi‐institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT‐2)
Cancer 2021cited by 61position: middledoi
A How-To Guide: Virtual Interviews in the Era of Social Distancing
Journal of Surgical Education 2021cited by 24position: contributordoi
Combined Inhibition of AKT and KIT Restores Expression of Programmed Cell Death 4 (PDCD4) in Gastrointestinal Stromal Tumor.
2021cited by 4position: contributordoi
Treatment at an Academic Cancer Center Confers Better Survival by Stage for Signet-Ring Cell and Non-signet-Ring Cell Gastric Cancer.
2021cited by 2position: contributordoi
Partial Gastrectomy is Associated with Improved Overall Survival in Signet-Ring Cell Gastric Cancer.
2021cited by 2position: contributordoi
Defining the role of neoadjuvant systemic therapy in high‐risk retroperitoneal sarcoma: A multi‐institutional study from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group
Cancer 2020cited by 48position: middledoi
Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis
Journal of the American College of Surgeons 2020cited by 23position: middledoi
Primary tumor characteristics and next-generation sequencing mutations as biomarkers for melanoma immunotherapy response.
2020cited by 5position: contributordoi
Long–Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis
Annals of Surgical Oncology 2019cited by 46position: middledoi
Soft tissue sarcoma of the extremity: Characterizing symptom duration and outcomes
Surgical Oncology 2019cited by 2position: contributordoi
Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network 2018cited by 315position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 12 papers (2019–2024)Harvey J. Mamon · Memorial Sloan Kettering Cancer Center3 papers (2023–2023)Martin R. Weiser · Sheba Medical Center3 papers (2023–2023)Marc J. Gollub · MACOM (United States)3 papers (2023–2023)Deborah Schrag · Worldwide Clinical Trials (United States)2 papers (2023–2023)Amylou C. Dueck · Mayo Clinic2 papers (2023–2023)Ethan Basch · UNC Lineberger Comprehensive Cancer Center2 papers (2023–2023)Alan P. Venook · University of California, San Francisco2 papers (2023–2023)Maureen V. Hill · 2 papers (2021–2022)Thomas J. George · University of Florida Health2 papers (2023–2023)Jeffrey A. Meyerhardt · Harvard University2 papers (2023–2023)Leonard B. Saltz · Cornell University2 papers (2023–2023)Qian Shi · Tongji University2 papers (2023–2023)George J. Chang · The University of Texas MD Anderson Cancer Center2 papers (2023–2023)Benjamin Musher · Baylor College of Medicine2 papers (2023–2023)Eileen M. O’Reilly · Erasmus MC Cancer Institute2 papers (2023–2023)Margaret von Mehren · Temple University Health System1 papers (2021–2021)Syeda Mahrukh Hussnain Naqvi · University of South Florida1 papers (2019–2019)Jonathan W. Serpell · Monash University1 papers (2019–2019) · 1 papers (2019–2019)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Oncology · Pulmonary and Respiratory Medicine →